YY1 downregulation restored the expression of myeloid C/EBP transcription factors and growth factors; increased the availability of RARα, making cells more sensitive to ATRA exposure; and restored apoptosis in AML cell lines. The gene discussed is RARA; the disease is acute myeloid leukemia.